Table 3 Safety data from VSV-S treatment
|  | Tumor bearing mice (n = 2) | Mice w/o tumor (n = 2) |
|---|---|---|
Hematology | ||
WBC (103/µL) | –a | 22.6 |
RBC (103/µL) | 3.2 | 9.8 |
HGB (g/dL) | 4.8 | 14.7 |
HCT (%) | 16.7 | 48.4 |
MCV (fL) | 52.0 | 50.5 |
MCH (pg) | 14.9 | 15.4 |
MCHC (g/dL) | 28.7 | 30.5 |
Platelet (103/µL) | 74 | 282 |
Lymphocytes (%) | 34.0 | 87.5 |
Neutrophil (%) | 52.0 | 8.0 |
Band (%) | 0 | 0 |
Monocytes (%) | 13.0 | 4.5 |
Eosinophils (%) | 1.0 | 0 |
Basophils (%) | 0 | 0 |
Clinical chemistry | ||
Hemolysis | +++ | ++++ |
Lipemia | Normal | Normal |
ALT (U/L) | 277.0 | 247.5 |
ALP (U/L) | 6.0 | 32.0 |
Albumin (g/dL) | 2.3 | 3.5 |
Total protein (g/dL) | 4.6 | 6.3 |
Glucose (mg/dL) | 92.0 | 78.0 |
Calcium (mg/dL) | 8.4 | 8.4 |
Phosphorus (mg/dL) | 8.7 | 15.1 |
BUN (mg/dL) | 28.0 | 26.5 |
PTT (s) | > 70 | > 70 |